Skip to main content

Table 3 Cox regression analysis for survival

From: Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study

   HR 95% CI p
Sex Male 0.803 0.594–1.086 0.154
Age (years) ≤65 1.063 0.797–1.417 0.678
Smoking status Yes 1.110 0.573–2.153 0.757
ECOG 0–4 1.684 1.450–1.956 < 0.001
Tumor size T1    < 0.001
T2 1.336 0.649–2.750
T3 2.214 1.089–4.501
T4 4.445 2.212–8.935
Lymph node Positive 4.132 2.660–6.418 < 0.001
Metastasis Yes 3.498 2.391–5.118 < 0.001
TNM stagea I + II    < 0.001
III 2.488 1.265–4.891
IV 5.474 3.107–9.645
ERCC1 ≤ 0.1 6.478 4.035–10.401 < 0.001
> 0.1
  1. aTNM stage was grouped as (I + II): III: IV